These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15645408)
41. In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective? Ruelas-Villavicencio AL; Vargas-Vorácková F Ann Hepatol; 2004; 3(4):152-9. PubMed ID: 15657557 [TBL] [Abstract][Full Text] [Related]
43. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C-Triggered Abbreviated MRI. Mulgaonkar A; Huang DQ; Siddiqi H; Fowler K; Sirlin CB; Marks R; Loomba R; Konijeti GG Am J Gastroenterol; 2024 Jul; 119(7):1326-1336. PubMed ID: 38146873 [TBL] [Abstract][Full Text] [Related]
44. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region. Amarapurkar D; Han KH; Chan HL; Ueno Y; J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082 [TBL] [Abstract][Full Text] [Related]
45. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C. Lin OS; Keeffe EB; Sanders GD; Owens DK Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169 [TBL] [Abstract][Full Text] [Related]
46. Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study. Wong WWL; Haines A; Bremner KE; Yao Z; Calzavara A; Mitsakakis N; Kwong JC; Sander B; Thein HH; Krahn MD CMAJ Open; 2021; 9(1):E167-E174. PubMed ID: 33688024 [TBL] [Abstract][Full Text] [Related]
47. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938 [TBL] [Abstract][Full Text] [Related]
48. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449 [TBL] [Abstract][Full Text] [Related]
50. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan. Younossi ZM; Tanaka A; Eguchi Y; Henry L; Beckerman R; Mizokami M J Viral Hepat; 2018 Aug; 25(8):945-951. PubMed ID: 29478258 [TBL] [Abstract][Full Text] [Related]
51. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection. Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823 [TBL] [Abstract][Full Text] [Related]
52. Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma. Hoshida Y; Shiratori Y; Omata M Liver; 2002 Dec; 22(6):479-85. PubMed ID: 12445173 [TBL] [Abstract][Full Text] [Related]
53. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Saab S; Ly D; Nieto J; Kanwal F; Lu D; Raman S; Amado R; Nuesse B; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Chen P; Schwegel K; Goldstein LI; Tong M; Busuttil RW Liver Transpl; 2003 Jul; 9(7):672-81. PubMed ID: 12827551 [TBL] [Abstract][Full Text] [Related]
54. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area. Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364 [TBL] [Abstract][Full Text] [Related]
55. The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma. Spolverato G; Vitale A; Ejaz A; Kim Y; Maithel SK; Cosgrove DP; Pawlik TM World J Surg; 2015 Jun; 39(6):1474-84. PubMed ID: 25665675 [TBL] [Abstract][Full Text] [Related]
56. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
57. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365 [TBL] [Abstract][Full Text] [Related]
58. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening. Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228 [TBL] [Abstract][Full Text] [Related]
59. The Effect of Hepatocellular Carcinoma Surveillance in an Urban Population With Liver Cirrhosis. Nusbaum JD; Smirniotopoulos J; Wright HC; Dash C; Parpia T; Shechtel J; Chang Y; Loffredo C; Shetty K J Clin Gastroenterol; 2015; 49(10):e91-5. PubMed ID: 25751372 [TBL] [Abstract][Full Text] [Related]
60. The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. White DL; Richardson P; Tayoub N; Davila JA; Kanwal F; El-Serag HB Gastroenterology; 2015 Dec; 149(7):1986-7. PubMed ID: 26519622 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]